These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: [The effect of etimizol on the glycosaminoglycan level in patients with osteoarthrosis deformans].
    Author: Neĭko IeM, Hlushko LV, Holovach IIu, Iatsyshyn RI.
    Journal: Lik Sprava; 1994; (7-8):73-5. PubMed ID: 7900360.
    Abstract:
    Aetymizolum was studied for its efficacy in the treatment of patients with osteoarthrosis. The results obtained suggest that aethymizolum is capable of correcting the levels of glycosaminoglucans in the patients' blood serum. With the content of the latter being dependent upon the degree of the articular cartilage destruction in osteoarthrosis deformans, it is suggested that aethymizolum while being endowed with reparative and membrane stabilizing properties may at the same time influence the articular cartilage metabolism and decrease the intensity of the destruction of the later. Effect of aethymizolum is more pronounced in mono-oligoarthrosis and polyosteoarthrosis as well as in stages II and III of the disease course. Conventional therapies (indomethacin, humisolum, Fibs, physiotherapeutic procedures, remedial gymnastics, massage) have no effect on these parameters.
    [Abstract] [Full Text] [Related] [New Search]